Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience
Eleni Gavriilaki(Aristotle University of Thessaloniki), Ioanna Sakellari(G. Papanikolaou General Hospital), Dimitrios Kazis(Aristotle University of Thessaloniki), Paraskevi Karvouni(Aristotle University of Thessaloniki), Christos Demosthenous(G. Papanikolaou General Hospital), Maria Gavriilaki(Aristotle University of Thessaloniki), Stefanos Bitsianis(Aristotle University of Thessaloniki), Marianna Masmanidou(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Sotirios Papagiannopoulos(G. Papanikolaou General Hospital), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), N. Kapravelos(G. Papanikolaou General Hospital), Georgia Vasileiadou(G. Papanikolaou General Hospital), Panagiotis Dolgyras(G. Papanikolaou General Hospital), Vasilios Κ. Kimiskidis(Aristotle University of Thessaloniki), Anna Vardi(G. Papanikolaou General Hospital), Militsa Bitzani(G. Papanikolaou General Hospital), Damianos Sotiropoulos(G. Papanikolaou General Hospital), Evangelia Yannaki(G. Papanikolaou General Hospital), Eulampia Stroggyli(G. Papanikolaou General Hospital), Asimina Bouinta(G. Papanikolaou General Hospital), D. Mallouri(G. Papanikolaou General Hospital), Zoi Bousiou(G. Papanikolaou General Hospital)
Cited by 6
Related Papers
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)
|Clinical Neurophysiology|2014|2.2k
Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines
|Clinical Neurophysiology|2020|1.5k
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
|JAMA Neurology|2017|274